Concord Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Cash & Equivalents	-	151.42	34.99	6.67	51.44	24.08
Short-Term Investments	-	228.22	305.8	872.5	550	-
Trading Asset Securities	-	2,437	1,369	734.73	1,410	1,981
Cash & Short-Term Investments	2,817	2,817	1,710	1,614	2,011	2,005
Cash Growth	64.71%	64.71%	5.96%	-19.76%	0.31%	-
Accounts Receivable	-	3,496	2,738	2,322	1,775	1,835
Other Receivables	-	159.99	217.95	272.74	358.19	133.64
Receivables	-	3,656	2,956	2,594	2,133	1,969
Inventory	-	2,080	2,123	1,951	1,536	1,112
Prepaid Expenses	-	73.31	55.19	47.61	45.44	40.23
Other Current Assets	-	336.73	433.05	119.5	345.27	259.47
Total Current Assets	-	8,962	7,277	6,327	6,071	5,386
Property, Plant & Equipment	-	7,865	7,655	6,436	5,577	3,809
Long-Term Investments	-	20.7	79.25	2.56	3.66	8.15
Other Intangible Assets	-	3.2	1.98	35.77	64.18	0.93
Other Long-Term Assets	-	156.1	126.8	327.4	108.69	201.1
Total Assets	-	17,007	15,140	13,128	11,825	9,405
Accounts Payable	-	944.35	938	831.06	463.97	712.33
Accrued Expenses	-	168.21	146.19	131.45	102.38	75.61
Short-Term Debt	-	-	-	43.37	50.99	-
Current Portion of Long-Term Debt	-	62.3	250	250	250	125
Current Portion of Leases	-	16.21	1.47	15.96	13.01	10.91
Current Income Taxes Payable	-	54.94	89.99	-	-	17.82
Current Unearned Revenue	-	-	13.13	32.72	-	-
Other Current Liabilities	-	175.55	479.67	247.1	177.04	209.28
Total Current Liabilities	-	1,422	1,918	1,552	1,057	1,151
Long-Term Debt	-	-	62.36	312.49	562.5	355.28
Long-Term Leases	-	18.87	1.64	3.11	16.33	29.35
Long-Term Deferred Tax Liabilities	-	280.65	234.39	209.71	174.53	151.29
Other Long-Term Liabilities	-	19.56	22.97	18.74	20.98	15.94
Total Liabilities	-	1,741	2,240	2,096	1,832	1,703
Common Stock	-	104.62	104.62	95.11	95.11	95.11
Additional Paid-In Capital	-	819.71	819.71	829.22	829.22	829.22
Retained Earnings	-	14,342	11,976	10,108	9,069	6,778
Shareholders' Equity	15,266	15,266	12,900	11,032	9,994	7,702
Total Liabilities & Equity	-	17,007	15,140	13,128	11,825	9,405
Total Debt	97.38	97.38	315.46	624.93	892.83	520.54
Net Cash (Debt)	2,719	2,719	1,395	988.98	1,118	1,485
Net Cash Growth	94.98%	94.98%	41.02%	-11.58%	-24.66%	-
Net Cash Per Share	26.00	25.99	13.33	9.45	10.69	14.19
Filing Date Shares Outstanding	104.55	104.62	104.62	104.62	104.62	104.62
Total Common Shares Outstanding	104.55	104.62	104.62	104.62	104.62	104.62
Working Capital	-	7,541	5,359	4,775	5,014	4,235
Book Value Per Share	145.93	145.93	123.31	105.45	95.53	73.62
Tangible Book Value	15,263	15,263	12,898	10,996	9,930	7,701
Tangible Book Value Per Share	145.90	145.90	123.29	105.11	94.91	73.62
Land	-	547.11	547.11	547.11	546.99	543.41
Buildings	-	2,576	2,463	2,226	1,981	735.36
Machinery	-	4,979	4,788	4,285	3,773	1,776
Construction In Progress	-	2,115	1,727	741.55	179.46	1,414

Source: S&P Capital IQ. Standard template. Financial Sources.